Work Here?
About HeartFlow
Industries
Healthcare
Company Size
501-1,000
Company Stage
Series F
Total Funding
$858.5M
Headquarters
Redwood City, California
Founded
2010
Overview
HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in the U.S., U.K., Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning. The goal is to improve cardiovascular care by making it safer and more efficient.
Simplify's Take
What believers are saying
- HeartFlow secured $215 million in Series F funding to scale operations and enhance products.
- The GAMEFILM Registry collaboration expands HeartFlow's market by addressing unique cardiovascular risks.
- HeartFlow's RoadMap Analysis increases adoption potential in clinical settings.
What critics are saying
- Emerging AI-driven competitors could threaten HeartFlow's market share with similar technologies.
- Algorithmic bias in AI models may lead to inaccurate diagnoses and legal liabilities.
- Regulatory hurdles in international markets could delay HeartFlow's product adoption.
What makes HeartFlow unique
- HeartFlow combines anatomy, physiology, and plaque analysis for comprehensive heart disease diagnostics.
- HeartFlow's non-invasive FFRCT Analysis offers personalized 3D heart models for precise treatment.
- HeartFlow's AI-driven technology aligns with updated AHA/ACC chest pain guidelines.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$858.5M
Above
Industry Average
Funded Over
9 Rounds
Benefits
Remote Work Options
Stock Options
401(k) Company Match
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 0%2 year growth
↓ -2%HeartFlow and Boone Heart Institute Launch GAMEFILM Registry to Study Heart Health in Retired NFL Players. by Fred Pennic 01/22/2025 Leave a Comment. What You Should Know: – HeartFlow, a global leader in AI-driven heart care solutions, and Boone Heart Institute, a renowned cardiovascular care provider in Denver, today announced the launch of the GAMEFILM Registry. – GAMEFILM Registry will utilize advanced imaging and AI technology to assess and better understand coronary artery disease (CAD) risk in retired National Football League (NFL) players.Understanding the Unique Cardiovascular Risks of Retired NFL PlayersCardiovascular disease remains the leading cause of death globally. Despite advancements in diagnostics, many heart attacks and strokes occur in individuals without prior symptoms. Early identification of high-risk individuals is critical for effective prevention and treatment. Retired NFL players often face unique cardiovascular health challenges due to the intense physical demands of their careers
HeartFlow announces new Category I CPT code from the American Medical Association for ai-enabled Plaque Analysis to assess risk for coronary artery disease.
HeartFlow launches plaque analysis platform for coronary artery disease.
Corcept appoints Monica Tellado as President, Emerging Markets.
Cardiovascular artificial intelligence (AI) software developer HeartFlow has released its RoadMap software for identifying stenoses in the coronary arteries on CT exams.
HeartFlow is Hiring for 28 Jobs on Simplify!
Find jobs on Simplify and start your career today
About HeartFlow
Industries
Healthcare
Company Size
501-1,000
Company Stage
Series F
Total Funding
$858.5M
Headquarters
Redwood City, California
Founded
2010
HeartFlow is Hiring for 28 Jobs on Simplify!
Find jobs on Simplify and start your career today